Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23124321 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention: Drug: Rituximab

Study has passed its completion date and status has not been verified in more than two years.